COVID 19, uma doença sistêmica

Barjud, Marina Bucar

doi:10.58969/25947125.4.0.2020.108

Cited by 4 publications

(3 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Given the consequences of SARS-CoV-2, patients may exhibit respiratory symptoms and experience involvement of various body systems such as the nervous, renal, digestive, and cardiovascular systems [ 16 ]. The multisystem nature of the disease often necessitates invasive procedures to support organ functions [ 2 ]. The diverse manifestations and clinical presentations of COVID-19 justify the presence of a wide range of NDs, encompassing both risk-focused and problem-focused diagnoses.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Nursing diagnoses in patients with COVID-19 admitted to the intensive care unit: CROSS-MAPPING

Leenara Bezerra da Silva,

Lopes de Moura,

Nayara do Nascimento Dantas

et al. 2024

Heliyon

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

“…In January of the same year, the World Health Organization (WHO) declared a Public Health Emergency of International Concern (PHEIC) to mitigate the widespread transmission of the virus. Consequently, in March 2020, considering the extensive geographic spread of COVID-19, it was classified as a pandemic state [ 1 , 2 ].…”

Section: Introductionmentioning

confidence: 99%

Nursing diagnoses in patients with COVID-19 admitted to the intensive care unit: CROSS-MAPPING

Leenara Bezerra da Silva,

Lopes de Moura,

Nayara do Nascimento Dantas

et al. 2024

Heliyon

View full text Add to dashboard Cite

“…This is due to the high affinity of SARS-CoV-2 for the transmembrane angiotensin-converting enzyme 2 (ACE2) protein, which is found in various tissues such as the kidneys, heart, lungs, and endothelial cells (Scholz et al, 2020). This results in an overproduction of inflammatory cytokines, leading to tissue damage in ACE2-expressing organs and increasing the risk for patients with pre-existing comorbidities (Barjud., 2020).…”

Section: Discussionmentioning

confidence: 99%

Trends in incidência of Covid-19 and clinical outcomes among patients with chronic kidney disease: insights from a retrospective study in Brazil

Da Silva,

Paiva,

Da Silva

et al. 2024

Cuad. Ed. Desar.

View full text Add to dashboard Cite

Chronic Kidney Disease (CKD) is closely associated with non-communicable chronic diseases, including Diabetes Mellitus (DM) and Systemic Arterial Hypertension (SAH). The COVID-19 pandemic has resulted in a high incidence of renal injuries, particularly in patients with pre-existing comorbidities. This study aimed to investigate the incidence of COVID-19 and its clinical outcomes among patients with CKD. A retrospective descriptive documental study with a quantitative approach was conducted at the Hospital Regional do Baixo Amazonas Dr. Waldemar Penna (HRBA) in Santarém, Brazil. Patient selection was done through a non-probabilistic convenience and random method. Data were collected from medical records over period from July to December 2020. The most common comorbidities associated with CKD were Systemic Arterial Hypertension (74.10%) and Diabetes Mellitus (33.33%). The study findings indicate a high incidence of COVID-19 among CKD patients, particularly in older age groups. The presence of comorbidities, such as Systemic Arterial Hypertension and Diabetes Mellitus, further increased the risk of COVID-19 complications in this population. The findings underscore the importance of early detection, proper management, and preventive measures to minimize the impact of COVID-19 in this vulnerable population.

show abstract

Neurological changes and physiotherapeutic performance in patients after COVID-19

Souza¹,

Carvalho²

2021

JRKS

View full text Add to dashboard Cite

COVID-19 is a pathology associated with the new coronavirus that has large-scale dissemination, resulting in a pandemic on 11/03/2020. Thus, it is worth emphasizing the importance of adopting measures such as social distancing, hand antisepsis and the use of masks, special attention with the elderly and people with comorbidities (risk groups), in addition to the relevance of testing, especially of symptomatic patients, as prophylactic measures, contributing to the attenuation of the progress of the pandemic. The general objective of the research is to discuss the physical therapy intervention, highlighting the method of proprioceptive neuromuscular facilitation, in view of the neurological manifestations of the central nervous system, with emphasis on stroke, in patients after COVID-19, and as specific objectives to describe the methods of prevention against this disease, to understand the anatomophysiology of the central nervous system, such as discussing about performing neurological physiotherapeutic evaluation in patients after COVID-19, in addition to the methods of diagnosis of this disease, its etiology and biomechanics and to understand how the physical therapist's action occurs in these cases, either in person or by telemonitoring, teleconsultation and teleconsulting due to the current scenario, and can then outline a physiotherapeutic prognosis. Therefore, the present work is an integrative review and for the accomplishment of this study were used the following descriptors: "neurological alterations", "therapeutic performance", "COVID-19", "stroke" and "proprioceptive neuromuscular facilitation" in languages such as Portuguese and English. The work was carried out between the months of August and November 2020, since in that period a systematic research was carried out on the topic of work. Studies published between the years 2010 to 2020 were used, but with a predominance of studies from the year 2020, in databases such as: LILACS, MEDLINE/PubMed and SciELO. Therefore, the new coronavirus can cause systemic changes, taking into account especially the neurological manifestations in the central nervous system of patients after COVID-19, requiring neurofunctional evaluation and physical therapy intervention. That said, it is possible to observe that although the main clinical characteristic of COVID-19 is respiratory, there are also neurological complications and in other systems that are related to the presence of receptors for angiotensin-2-converter enzyme, and neurological deficits due to cerebrovascular disease in patients after COVID-19 may occur more pronouncedly in the acute phase and in the most severe form of the disease. Thus, in order to mitigate the severity of neurological complications and sequelae resulting from COVID-19, the physiotherapist participates in both prevention and health promotion, with physical therapy intervention being performed in person or through telemonitoring, teleconsultation and teleconsulting, in search of a promising prognosis for patient’s victims of COVID-19. However, in view of the neurological alterations manifested in patients after COVID-19, the physiotherapist will have an indispensable role to play in order to bring functionality and improve the quality of life of these patients, reinserting them into society after significant rehabilitation.

show abstract

COVID 19, uma doença sistêmica

Cited by 4 publications

References 1 publication

Nursing diagnoses in patients with COVID-19 admitted to the intensive care unit: CROSS-MAPPING

Nursing diagnoses in patients with COVID-19 admitted to the intensive care unit: CROSS-MAPPING

Trends in incidência of Covid-19 and clinical outcomes among patients with chronic kidney disease: insights from a retrospective study in Brazil

Neurological changes and physiotherapeutic performance in patients after COVID-19

Contact Info

Product

Resources

About